药物是一种涉及国民健康、社会稳定和经济发展的特殊产品，药物的研发融合了多学科先进技术和高科技产业的精华。近年，医药行业增长速度迅猛，成为国民经济发展最快的行业之一。2016年，制药产业持续繁荣，同时也呈现出诸多新的特点。本文以2016年度批准的重磅新药为依据，盘点肿瘤、糖尿病、心血管、阿尔茨海默病、自身免疫性疾病、感染性疾病等治疗领域药物研发的新靶标、新技术、新方法等热点。
Medicine is a kind of special product that relates to national health, social stability and economic development. In recent years, the pharmaceutical industry has become one of the fastest growing industries in the national economy. In 2016, the pharmaceutical industry continued its prosperity and exhibited many new characteristics. This paper, based on the new heavy drugs approved in the year, summarizes the new targets, new technologies, new methods and so on, in the fields of cancer, diabetes, cardiovascular disease, Alzheimer's disease, autoimmune diseases and infectious diseases.
[1] Cyranoski D. CRISPR gene-editing tested in a person for the first time[J]. Nature, 2016, 539(7630):479.
[2] Hultquist J F, Schumann K, Woo J M, et al. A Cas9 ribonucleoprotein platform for functional genetic studies of HIV-Host interactions in primary human T cells[J]. Cell Reports, 2016, 17(5):1438-1452.
[3] Sykes D B, Kfoury Y S, Mercier F E, et al. Inhibition of dihydroorotate dehydrogenase overcomes differentiation blockade in acute myeloid leukemia[J]. Cell, 2016, 167(1):171-186.
[4] 世界卫生组织发布《2014年世界癌症报告》[J].中国卫生政策研究, 2014(2):16.
[5] 毛艳艳, 高柳滨. 全球抗肿瘤药物研发报告全球抗肿瘤药物研发报告(2016)[J]. 科技导报, 2016, 34(11):21-24.
[6] 全球肿瘤快讯. 美国癌症研究会发布2016年癌症进展报告[EB/OL].[2016-10-09]. http://www.bjcancer.org/Hospitals/Journals/ArticleIndex/3688.
[7] Postow M A, Chesney J, Pavlick A C, et al. Nivolumab and ipilimumab versus ipilimumab in untreated melanoma[J]. New England Journal of Medicine, 2015, 372(21):2006-2017.
[8] 陈洪兴. 贝伐单抗联合培美曲塞加铂类治疗晚期肺腺癌的可行性及安全性[J]. 吉林医学, 2016, 37(5):1169-1170.
[9] Im S J, Hashimoto M, Gerner M Y, et al. Defining CD8(+) T cells that provide the proliferative burst after PD-1 therapy[J]. Nature, 2016, 537(7620):417-421.
[10] Dorand R D, Nthale J, Myers J T, et al. Cdk5 disruption attenuates tumor PD-L1 expression and promotes antitumor immunity[J]. Science, 2016, 353(6297):399-403.
[11] Kranz L M, Diken M, Haas H, et al. Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy[J]. Nature, 2016, 534:396-401.
[12] Formulation of insulin for oral dosing[C]//252nd National Meeting & Exposition of the American Chemical Society, Philadelphia, 2016-08-24.
[13] Pijacka W, Moraes D J, Ratcliffe L E, et al. Purinergic receptors in the carotid body as a new drug target for controlling hypertension[J]. Nature Medicine, 2016, 22(10):1151-1159.
[14] Nioi P, Sigurdsson A, Thorleifsson G, et al. Variant ASGR1 associated with a reduced risk of coronary artery disease[J]. New England Journal of Medicine, 2016, 374(22):2131-2141.
[15] Abbott A, Dolgin E. Failed Alzheimer's trial does not kill leading theory of disease[J]. Nature, 2016, 540(7631):15.
[16] Novak P, Schmidt R, Kontsekova E, et al. Safety and immunogenicity of the tau vaccine AADvac1 in patients with Alzheimer's disease:Arandomised, double-blind, placebo-controlled, phase 1 trial[J]. Lancet Neurology, 2016, in press.
[17] Kennedy M E, Stamford A W, Chen X, et al. The BACE1 inhibitor verubecestat (MK-8931) reduces CNS β-amyloid in animal models and in Alzheimer's disease patients.[J]. Science Translational Medicine, 2016, 8(363):363ra150-363ra150.
[18] Katsouri L, Lim Y M, Blondrath K, et al. PPARγ-coactivator-1α gene transfer reduces neuronal loss and amyloid-β generation by reducing β-secretase in an Alzheimer's disease model[J]. Proceedings of the National Academy of Sciences of the United States of America, 2016, 113(43):12292-12297.
[19] Wälti MA, Ravotti F, Arai H, et al. Atomic-resolution structure of a disease-relevant Aβ(1-42) amyloid fibril[J]. Proceedings of the National Academy of Sciences of the United States of America, 2016, 113(34):201600749.
[20] Currais A, Quehenberger O, Armando A M, et al. Amyloid proteotoxicity initiates an inflammatory response blocked by cannabinoids[J]. NPJ Aging and Mechanisms of Disease, 2016, 2:16012.
[21] 刘丽丽, 毛艳艳, 高柳滨. 类风湿关节炎全球药物研发状况分析[J]. 科技导报, 2016, 34(24):44-55.
[22] Borducchi E N, Cabral C, Stephenson K E, et al. Ad26/MVA therapeutic vaccination with TLR7 stimulation in SIV-infected rhesus monkeys[J]. Nature, 2016, 540(7632):284-287.
[23] Lee J H, Ozorowski G, Ward A B. Cryo-EM structure of a native, fully glycosylated, cleaved HIV-1 envelope trimer[J]. Science, 2016, 351(6277):1043-1048.
